NEWS
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement
Autonomix Medical, Inc. (NASDAQ: AMIX), a medical device company focused on innovative technologies for diagnosing and treating nervous system diseases, recently participated in a Virtual Investor 'What This Means' segment. CEO Brad Hauser discussed the company's recent definitive agreement with RF Innovations, Inc. to license the intellectual property for its Apex 6 Radiofrequency Generator.
The agreement is significant for Autonomix's development program, as it provides access to FDA-cleared ablation technology. This move aligns with the company's mission to revolutionize nervous system disease management. The segment, which offers insights into the implications of this licensing agreement, is now available for viewing online.
The agreement is significant for Autonomix's development program, as it provides access to FDA-cleared ablation technology. This move aligns with the company's mission to revolutionize nervous system disease management. The segment, which offers insights into the implications of this licensing agreement, is now available for viewing online.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1065Followers
68Following
7319Visitors
Follow